Dilated Cardiomyopathy Therapeutics Market Insights, Global Outlook and Forecast 2022-2028
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Dilated cardiomyopathy (DCM) is a condition in which the heart's ability to pump blood is decreased because the heart's main pumping chamber, the left ventricle, is enlarged and weakened. In some cases, it prevents the heart from relaxing and filling with blood as it should.
The latest research study released by Market IntelliX evaluates market size and forecasts of Dilated Cardiomyopathy Therapeutics in Global, including the following market information:
Global Dilated Cardiomyopathy Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Dilated Cardiomyopathy Therapeutics market was valued at 28 million in 2021 and is projected to reach US$ 33 million by 2028, at a CAGR of 2.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drug Class Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dilated Cardiomyopathy Therapeutics include Aastrom Biosciences, Capricor Therapeutics, GlaxoSmithkline Plc, Johnson and Johnson, Kasiak Research Pvt. Ltd., Merck & Co., Inc., MyoKardia, Pfizer, Inc., t2cure, GmbH and Teva Pharmaceutical Industries and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Dilated Cardiomyopathy Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Dilated Cardiomyopathy Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Dilated Cardiomyopathy Therapeutics Market Segment Percentages, by Type, 2021 (%)
Drug Class
Implantable Device
Pipeline Analysis
Global Dilated Cardiomyopathy Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Dilated Cardiomyopathy Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinic
Others
Global Dilated Cardiomyopathy Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Dilated Cardiomyopathy Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dilated Cardiomyopathy Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Dilated Cardiomyopathy Therapeutics revenues share in global market, 2021 (%)
The report presents profiles of competitors in the market, Some of the prominent key players covered:
Aastrom Biosciences
Capricor Therapeutics
GlaxoSmithkline Plc
Johnson and Johnson
Kasiak Research Pvt. Ltd.
Merck & Co., Inc.
MyoKardia, Pfizer, Inc.
t2cure, GmbH
Teva Pharmaceutical Industries
ZensunSci & Tech
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Dilated Cardiomyopathy Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dilated Cardiomyopathy Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dilated Cardiomyopathy Therapeutics Overall Market Size
2.1 Global Dilated Cardiomyopathy Therapeutics Market Size: 2021 VS 2028
2.2 Global Dilated Cardiomyopathy Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Dilated Cardiomyopathy Therapeutics Players in Global Market
3.2 Top Global Dilated Cardiomyopathy Therapeutics Companies Ranked by Revenue
3.3 Global Dilated Cardiomyopathy Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Dilated Cardiomyopathy Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Dilated Cardiomyopathy Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dilated Cardiomyopathy Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Dilated Cardiomyopathy Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Dilated Cardiomyopathy Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Dilated Cardiomyopathy Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Drug Class
4.1.3 Implantable Device
4.1.4 Pipeline Analysis
4.2 By Type - Global Dilated Cardiomyopathy Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Dilated Cardiomyopathy Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Dilated Cardiomyopathy Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Dilated Cardiomyopathy Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dilated Cardiomyopathy Therapeutics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Dilated Cardiomyopathy Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Dilated Cardiomyopathy Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Dilated Cardiomyopathy Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Dilated Cardiomyopathy Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Dilated Cardiomyopathy Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Dilated Cardiomyopathy Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Dilated Cardiomyopathy Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Dilated Cardiomyopathy Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Dilated Cardiomyopathy Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Dilated Cardiomyopathy Therapeutics Revenue, 2017-2028
6.3.2 US Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.3.3 Canada Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.3.4 Mexico Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Dilated Cardiomyopathy Therapeutics Revenue, 2017-2028
6.4.2 Germany Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.4.3 France Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.4.4 U.K. Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.4.5 Italy Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.4.6 Russia Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.4.8 Benelux Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Dilated Cardiomyopathy Therapeutics Revenue, 2017-2028
6.5.2 China Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.5.3 Japan Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.5.4 South Korea Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.5.6 India Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Dilated Cardiomyopathy Therapeutics Revenue, 2017-2028
6.6.2 Brazil Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.6.3 Argentina Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Dilated Cardiomyopathy Therapeutics Revenue, 2017-2028
6.7.2 Turkey Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.7.3 Israel Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
6.7.5 UAE Dilated Cardiomyopathy Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Aastrom Biosciences
7.1.1 Aastrom Biosciences Corporate Summary
7.1.2 Aastrom Biosciences Business Overview
7.1.3 Aastrom Biosciences Dilated Cardiomyopathy Therapeutics Major Product Offerings
7.1.4 Aastrom Biosciences Dilated Cardiomyopathy Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Aastrom Biosciences Key News
7.2 Capricor Therapeutics
7.2.1 Capricor Therapeutics Corporate Summary
7.2.2 Capricor Therapeutics Business Overview
7.2.3 Capricor Therapeutics Dilated Cardiomyopathy Therapeutics Major Product Offerings
7.2.4 Capricor Therapeutics Dilated Cardiomyopathy Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Capricor Therapeutics Key News
7.3 GlaxoSmithkline Plc
7.3.1 GlaxoSmithkline Plc Corporate Summary
7.3.2 GlaxoSmithkline Plc Business Overview
7.3.3 GlaxoSmithkline Plc Dilated Cardiomyopathy Therapeutics Major Product Offerings
7.3.4 GlaxoSmithkline Plc Dilated Cardiomyopathy Therapeutics Revenue in Global Market (2017-2022)
7.3.5 GlaxoSmithkline Plc Key News
7.4 Johnson and Johnson
7.4.1 Johnson and Johnson Corporate Summary
7.4.2 Johnson and Johnson Business Overview
7.4.3 Johnson and Johnson Dilated Cardiomyopathy Therapeutics Major Product Offerings
7.4.4 Johnson and Johnson Dilated Cardiomyopathy Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Johnson and Johnson Key News
7.5 Kasiak Research Pvt. Ltd.
7.5.1 Kasiak Research Pvt. Ltd. Corporate Summary
7.5.2 Kasiak Research Pvt. Ltd. Business Overview
7.5.3 Kasiak Research Pvt. Ltd. Dilated Cardiomyopathy Therapeutics Major Product Offerings
7.5.4 Kasiak Research Pvt. Ltd. Dilated Cardiomyopathy Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Kasiak Research Pvt. Ltd. Key News
7.6 Merck & Co., Inc.
7.6.1 Merck & Co., Inc. Corporate Summary
7.6.2 Merck & Co., Inc. Business Overview
7.6.3 Merck & Co., Inc. Dilated Cardiomyopathy Therapeutics Major Product Offerings
7.6.4 Merck & Co., Inc. Dilated Cardiomyopathy Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Merck & Co., Inc. Key News
7.7 MyoKardia, Pfizer, Inc.
7.7.1 MyoKardia, Pfizer, Inc. Corporate Summary
7.7.2 MyoKardia, Pfizer, Inc. Business Overview
7.7.3 MyoKardia, Pfizer, Inc. Dilated Cardiomyopathy Therapeutics Major Product Offerings
7.7.4 MyoKardia, Pfizer, Inc. Dilated Cardiomyopathy Therapeutics Revenue in Global Market (2017-2022)
7.7.5 MyoKardia, Pfizer, Inc. Key News
7.8 t2cure, GmbH
7.8.1 t2cure, GmbH Corporate Summary
7.8.2 t2cure, GmbH Business Overview
7.8.3 t2cure, GmbH Dilated Cardiomyopathy Therapeutics Major Product Offerings
7.8.4 t2cure, GmbH Dilated Cardiomyopathy Therapeutics Revenue in Global Market (2017-2022)
7.8.5 t2cure, GmbH Key News
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Corporate Summary
7.9.2 Teva Pharmaceutical Industries Business Overview
7.9.3 Teva Pharmaceutical Industries Dilated Cardiomyopathy Therapeutics Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Dilated Cardiomyopathy Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Teva Pharmaceutical Industries Key News
7.10 ZensunSci & Tech
7.10.1 ZensunSci & Tech Corporate Summary
7.10.2 ZensunSci & Tech Business Overview
7.10.3 ZensunSci & Tech Dilated Cardiomyopathy Therapeutics Major Product Offerings
7.10.4 ZensunSci & Tech Dilated Cardiomyopathy Therapeutics Revenue in Global Market (2017-2022)
7.10.5 ZensunSci & Tech Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Research Methodology:
Dilated Cardiomyopathy Therapeutics Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|